Your browser doesn't support javascript.
loading
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
Mantero, Julio C; Kishore, Nina; Ziemek, Jessica; Stifano, Giuseppina; Zammitti, Christopher; Khanna, Dinesh; Gordon, Jessica K; Spiera, Robert; Zhang, Yuqing; Simms, Robert W; Lafyatis, Robert.
Afiliación
  • Mantero JC; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Kishore N; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Ziemek J; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Stifano G; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Zammitti C; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Khanna D; Department of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, USA.
  • Gordon JK; Department of Rheumatology, Hospital of Special Surgery, New York, NY, USA.
  • Spiera R; Department of Rheumatology, Hospital of Special Surgery, New York, NY, USA.
  • Zhang Y; Division of Epidemiology, Massachusetts General Hospital, Boston, MA, USA.
  • Simms RW; Department of Rheumatology, Boston University Medical Center, Boston, MA, USA.
  • Lafyatis R; Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. rlafyatis@gmail.com.
Clin Exp Rheumatol ; 36 Suppl 113(4): 146-149, 2018.
Article en En | MEDLINE | ID: mdl-30277862
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Proteínas Recombinantes de Fusión / Esclerodermia Difusa / Antiinflamatorios Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Exp Rheumatol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Proteínas Recombinantes de Fusión / Esclerodermia Difusa / Antiinflamatorios Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Exp Rheumatol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos